Literature DB >> 1332976

Transforming growth factor-beta: recent progress and new challenges.

M B Sporn1, A B Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1332976      PMCID： PMC2289722          DOI： 10.1083/jcb.119.5.1017

Source DB:  PubMed          Journal:  J Cell Biol        ISSN： 0021-9525            Impact factor:   10.539


× No keyword cloud information.
  38 in total

1.  Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

Authors:  H Y Lin; X F Wang; E Ng-Eaton; R A Weinberg; H F Lodish
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  Is there a common pathway mediating growth inhibition by TGF-beta and the retinoblastoma gene product?

Authors:  A B Roberts; S J Kim; M B Sporn
Journal:  Cancer Cells       Date:  1991-01

3.  Redox regulation of fos and jun DNA-binding activity in vitro.

Authors:  C Abate; L Patel; F J Rauscher; T Curran
Journal:  Science       Date:  1990-09-07       Impact factor: 47.728

4.  Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.

Authors:  A M Manning; A C Williams; S M Game; C Paraskeva
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

5.  Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.

Authors:  A Miller; O Lider; A B Roberts; M B Sporn; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

6.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.

Authors:  S Cheifetz; T Bellón; C Calés; S Vera; C Bernabeu; J Massagué; M Letarte
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

7.  Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.

Authors:  A Butta; K MacLennan; K C Flanders; N P Sacks; I Smith; A McKinna; M Dowsett; L M Wakefield; M B Sporn; M Baum
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

8.  Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product.

Authors:  J A Pietenpol; K Münger; P M Howley; R W Stein; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

Review 9.  Cytokines in context.

Authors:  C Nathan; M Sporn
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

10.  Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.

Authors:  R Flaumenhaft; M Abe; P Mignatti; D B Rifkin
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539
View more
  130 in total

1.  Extraction and purification of TGFbeta and its effect on the induction of apoptosis of hepatocytes.

Authors:  X H Si; L J Yang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Age-related changes in wound healing.

Authors:  D R Thomas
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells.

Authors:  M Harada; K Tatsugami; M Nomoto; K Nomoto
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

4.  Normal rat intestinal cells IEC-18: characterization and transfection with immortalizing oncogenes.

Authors:  O Vincentini; C Ciotta; M Bignami; A Stammati; F Zucco
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

5.  Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice.

Authors:  C W Yang; C C Yu; Y C Ko; C C Huang
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.

Authors:  K Sellheyer; J R Bickenbach; J A Rothnagel; D Bundman; M A Longley; T Krieg; N S Roche; A B Roberts; D R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  TGFB2 and BCL2L11 methylation in male laryngeal cancer patients.

Authors:  Zhisen Shen; Xiaoying Chen; Qun Li; Huadan Ye; Jinyun Li; Chongchang Zhou; Shiwei Duan
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

8.  The alteration of prostaglandin E2 levels in patients with brain tumors before and after tumor removal.

Authors:  Joon-Khim Loh; Shiuh-Lin Hwang; Ann-Shung Lieu; Tzuu-Yuan Huang; Shen-Long Howng
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

9.  Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.

Authors:  H Zhang; T Morisaki; H Matsunaga; N Sato; A Uchiyama; K Hashizume; F Nagumo; J Tadano; M Katano
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

10.  Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis.

Authors:  K Zhang; K C Flanders; S H Phan
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.